1. Home
  2. XGN vs JHI Comparison

XGN vs JHI Comparison

Compare XGN & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • JHI
  • Stock Information
  • Founded
  • XGN 2002
  • JHI 1971
  • Country
  • XGN United States
  • JHI United States
  • Employees
  • XGN N/A
  • JHI N/A
  • Industry
  • XGN Medical Specialities
  • JHI Trusts Except Educational Religious and Charitable
  • Sector
  • XGN Health Care
  • JHI Finance
  • Exchange
  • XGN Nasdaq
  • JHI Nasdaq
  • Market Cap
  • XGN 138.3M
  • JHI 125.7M
  • IPO Year
  • XGN 2019
  • JHI N/A
  • Fundamental
  • Price
  • XGN $9.74
  • JHI $14.17
  • Analyst Decision
  • XGN Strong Buy
  • JHI
  • Analyst Count
  • XGN 5
  • JHI 0
  • Target Price
  • XGN $12.40
  • JHI N/A
  • AVG Volume (30 Days)
  • XGN 217.1K
  • JHI 29.5K
  • Earning Date
  • XGN 11-11-2025
  • JHI 01-01-0001
  • Dividend Yield
  • XGN N/A
  • JHI 6.80%
  • EPS Growth
  • XGN N/A
  • JHI N/A
  • EPS
  • XGN N/A
  • JHI 1.05
  • Revenue
  • XGN $58,862,000.00
  • JHI N/A
  • Revenue This Year
  • XGN $22.09
  • JHI N/A
  • Revenue Next Year
  • XGN $13.62
  • JHI N/A
  • P/E Ratio
  • XGN N/A
  • JHI $12.47
  • Revenue Growth
  • XGN 3.89
  • JHI N/A
  • 52 Week Low
  • XGN $2.38
  • JHI $11.63
  • 52 Week High
  • XGN $10.34
  • JHI $13.40
  • Technical
  • Relative Strength Index (RSI)
  • XGN 56.30
  • JHI 50.45
  • Support Level
  • XGN $9.55
  • JHI $14.13
  • Resistance Level
  • XGN $10.28
  • JHI $14.51
  • Average True Range (ATR)
  • XGN 0.37
  • JHI 0.09
  • MACD
  • XGN -0.08
  • JHI 0.01
  • Stochastic Oscillator
  • XGN 34.94
  • JHI 20.93

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

About JHI John Hancock Investors Trust

John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.

Share on Social Networks: